Rates at a Glance
The rates below are from the December 17, 2019 Federal Rate Agreement. If you have questions regarding the use of this rate agreement, please contact the Division of Research – Office of Contracts and Grants.
|9/1/2017 - 8/31/2021||53.00% (predetermined)||53.00% (predetermined)|
|9/1/2020 - 8/31/2023||55.00% (predetermined)||55.00% (predetermined)|
Facilities & Administration Costs (formerly known as Indirect Costs)
The base for F&A Costs is the Modified Total Direct Costs (MTDC).
|Period||On-Campus Research||On-Campus Other Sponsored Activities|
|9/1/2019 - 8/31/2021||53.00%||33.00%|
|9/1/2020 - 8/31/2023||55.00%||33.00%|
|Period||Off-Campus Research||Off-Campus Other Sponsored Activities|
|9/1/2019 - 8/31/2023||26.00%||26.00%|
*Clinical Trial Rates
|2/1/2019 - 6/30/2021||31.00%|
Modified total direct costs, consisting of all direct salaries and wages, applicable fringe benefits, materials and supplies, services, travel and up to the first $25,000 of each subaward (regardless of the period of performance of the subawards under the award). Modified total direct costs shall exclude equipment, capital expenditures, charges for patient care, rental costs, tuition remission, scholarships and fellowships, participant support costs and the portion of each subaward in excess of $25,000.
Other items may only be excluded when necessary to avoid a serious inequity in the distribution of indirect costs, and with the approval of the cognizant agency for indirect costs.
*Clinical trial rate is applied to the Total Direct Cost; no budgeted item is excluded from the application of indirect costs. This rate applies regardless of whether a Clinical Trial is based on a sponsor-initiated, or an investigator-Initiated protocol.